Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pruijt

Showing results (21-30 of 46) with videos related to

Pageof 5
Sort By:
Blood|June 19, 2002
Enhancement of G-CSF-induced stem cell mobilization by antibodies against the beta 2 integrins LFA-1 and Mac-1Gerjo A Velders, Johannes F M Pruijt, Perry Verzaal, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2009
New opportunities for drug outcomes research in cancer patients: the linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage SystemMyrthe P P van Herk-Sukel, Lonneke V van de Poll-Franse, Valery E P P Lemmens, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 14, 2025
Intestinal Ultrasound and Its Advanced Modalities in Characterizing Strictures in Crohn's DiseaseF de Voogd, K J Beek, M Pruijt, et al.
Journal of Geriatric Oncology|September 24, 2016
The impact of age on first-line systemic therapy in patients with metachronous metastases from colorectal cancerLieke G E M Razenberg, Felice N van Erning, Hans F M Pruijt, et al.
European Journal of Cancer (Oxford, England : 1990)|April 30, 2016
Intensity of adjuvant chemotherapy regimens and grade III-V toxicities among elderly stage III colon cancer patientsF N van Erning, L G E M Razenberg, V E P P Lemmens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 24, 2013
Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinomaN Hugen, R H A Verhoeven, S A Radema, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 14, 2013
Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based studyM M J Zanders, L N van Steenbergen, H R Haak, et al.
BMC Surgery|May 17, 2011
The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ StudyDaniel J Lips, Boukje Koebrugge, Gerrit Jan Liefers, et al.
Pathology, Research and Practice|August 23, 2020
Node negative colorectal cancer patients: assesment of high-risk features on recurrenceR L A van der Linden, L L Rijstenberg, J C van der Linden, et al.
British Journal of Haematology|April 2, 2022
Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: A longitudinal PROFILES registry studyAfke Ekels, Lonneke V van de Poll-Franse, Eduardus F M Posthuma, et al.
Pageof 5

Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
Blood|June 19, 2002
Enhancement of G-CSF-induced stem cell mobilization by antibodies against the beta 2 integrins LFA-1 and Mac-1Gerjo A Velders, Johannes F M Pruijt, Perry Verzaal, et al.
European Journal of Cancer (Oxford, England : 1990)|October 9, 2009
New opportunities for drug outcomes research in cancer patients: the linkage of the Eindhoven Cancer Registry and the PHARMO Record Linkage SystemMyrthe P P van Herk-Sukel, Lonneke V van de Poll-Franse, Valery E P P Lemmens, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 14, 2025
Intestinal Ultrasound and Its Advanced Modalities in Characterizing Strictures in Crohn's DiseaseF de Voogd, K J Beek, M Pruijt, et al.
Journal of Geriatric Oncology|September 24, 2016
The impact of age on first-line systemic therapy in patients with metachronous metastases from colorectal cancerLieke G E M Razenberg, Felice N van Erning, Hans F M Pruijt, et al.
European Journal of Cancer (Oxford, England : 1990)|April 30, 2016
Intensity of adjuvant chemotherapy regimens and grade III-V toxicities among elderly stage III colon cancer patientsF N van Erning, L G E M Razenberg, V E P P Lemmens, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 24, 2013
Prognosis and value of adjuvant chemotherapy in stage III mucinous colorectal carcinomaN Hugen, R H A Verhoeven, S A Radema, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|June 14, 2013
Diminishing differences in treatment between patients with colorectal cancer with and without diabetes: a population-based studyM M J Zanders, L N van Steenbergen, H R Haak, et al.
BMC Surgery|May 17, 2011
The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ StudyDaniel J Lips, Boukje Koebrugge, Gerrit Jan Liefers, et al.
Pathology, Research and Practice|August 23, 2020
Node negative colorectal cancer patients: assesment of high-risk features on recurrenceR L A van der Linden, L L Rijstenberg, J C van der Linden, et al.
British Journal of Haematology|April 2, 2022
Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: A longitudinal PROFILES registry studyAfke Ekels, Lonneke V van de Poll-Franse, Eduardus F M Posthuma, et al.
Pageof 5